CNR Institutional Research Information System

SCIANDRA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.953
NA - Nord America 1.541
EU - Europa 1.202
SA - Sud America 437
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 41
OC - Oceania 2
Totale 5.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.463
SG - Singapore 790
RU - Federazione Russa 656
CN - Cina 406
BR - Brasile 331
VN - Vietnam 243
HK - Hong Kong 207
IT - Italia 187
FR - Francia 138
KR - Corea 69
BD - Bangladesh 55
GB - Regno Unito 55
JP - Giappone 49
AR - Argentina 43
CA - Canada 41
DE - Germania 38
IN - India 34
NL - Olanda 34
ID - Indonesia 21
FI - Finlandia 20
CO - Colombia 19
EC - Ecuador 18
ZA - Sudafrica 15
MX - Messico 12
TR - Turchia 12
IL - Israele 11
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
BE - Belgio 7
CL - Cile 7
EG - Egitto 7
ES - Italia 7
LT - Lituania 7
PK - Pakistan 7
UA - Ucraina 7
AT - Austria 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
JM - Giamaica 5
HN - Honduras 4
IE - Irlanda 4
OM - Oman 4
PA - Panama 4
PY - Paraguay 4
TH - Thailandia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
JO - Giordania 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PH - Filippine 2
SC - Seychelles 2
SE - Svezia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
ZM - Zambia 1
Totale 5.178
Salva come PNG Salva come JPEG
Città #
Santa Clara 510
Singapore 460
Hong Kong 202
San Jose 173
Hefei 163
Lauterbourg 94
Beijing 91
Ashburn 89
Ho Chi Minh City 86
Seoul 69
Los Angeles 59
Hanoi 55
Rome 54
Dallas 46
Milan 45
Tokyo 38
São Paulo 28
New York 21
Frankfurt am Main 20
Rio de Janeiro 16
London 15
Council Bluffs 14
Haiphong 14
Orem 14
Chennai 12
Buffalo 11
Brasília 10
Da Nang 10
Houston 10
Lappeenranta 10
Dhaka 9
Helsinki 9
Johannesburg 9
Phoenix 9
Porto Alegre 9
Toronto 9
Belo Horizonte 8
Brooklyn 8
Minamishinagawa 8
Naples 8
Bogotá 7
Brussels 7
Montreal 7
Bengaluru 6
Buenos Aires 6
Las Vegas 6
Baghdad 5
Bexley 5
Bristol 5
Campinas 5
Can Tho 5
Cleveland 5
Curitiba 5
Guayaquil 5
Hải Dương 5
Lahore 5
Manchester 5
Aracaju 4
Baku 4
Bergamo 4
Cairo 4
Caracas 4
Carapicuíba 4
Chicago 4
Detroit 4
Dublin 4
Düsseldorf 4
Fort Worth 4
Lấp Vò 4
Miami 4
Ninh Bình 4
Nuremberg 4
Ottawa 4
Palermo 4
Pittsburgh 4
Portsmouth 4
Queens 4
Roubaix 4
San Francisco 4
St Louis 4
São José do Rio Preto 4
Treviso 4
Vienna 4
Warsaw 4
Acalanes Ridge 3
Amman 3
Anápolis 3
Athens 3
Blumenau 3
Boardman 3
Bologna 3
Boston 3
Bình An 3
Bình Dương Province 3
Bắc Giang 3
Canton 3
Cao Lanh 3
Crawfordville 3
Dakar 3
Didcot 3
Totale 2.775
Salva come PNG Salva come JPEG
Nome #
Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology 724
Molecular mechanisms underlying muscle wasting in huntington's disease 97
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line 96
Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks 92
The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization 82
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin 80
From adhesion complex to signaling hub: the dual role of dystroglycan 78
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 72
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core portein in some, but not all, dystroglycanopathy patients 71
Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation 70
3D Graphene Scaffolds for Skeletal Muscle Regeneration: Future Perspectives 68
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1 67
Multifunctional scaffolds for biomedical applications: Crafting versatile solutions with polycaprolactone enriched by graphene oxide 66
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 65
Molecular and structural basis of dystroglycanopathies 62
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 60
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 59
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. 58
Structural flexibility of human ?lpha-dystroglycan 58
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 58
Identification and Modeling of a GT-A Fold in the ?-Dystroglycan Glycosylating Enzyme LARGE1 56
Advanced approaches in skin wound healing - a review on the multifunctional properties of MXenes in therapy and sensing 54
Alpha-dystroglycan is a potential target of matrix metalloproteinase MMP-2 53
Perturbation of the alpha/beta-dystroglycan interaction: consequences for skeletal muscle stability 52
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. 52
Punicalagin Protects Human Retinal Pigment Epithelium Cells From Ultraviolet Radiation-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway and Reducing Apoptosis 52
Structural flexibility of human alpha-dystroglycan 51
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 51
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 50
Modeling and molecular dynamics of alpha-dystroglycan's C-terminus reveals the presence of an Ig-like domain encompassing its beta-dystroglycan binding epitope 50
The enzymatic processing of ?-dystroglycan by MMP-2 is controller by two anchoring sites distinct from the active site 50
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site 49
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 47
Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation 47
BPS2025 - Novel 3D-printed wound healing transwell system for reproducible analysis of skin dressing 47
Live optical super-resolution microcospy applied to the characterization of maturation, localization and trafficking of defective dystroglycan mutants 46
Extracellular Vesicle Molecular Profiling for Diagnostic Purposes: An Application of Phage Display Technology 45
Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro 45
Analisi strutturale e funzionale dei domini del distroglicano: ruolo per la stabilità del muscolo e aspetti fisiopatologici 45
Insights from molecular dynamics simulations: Structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model 44
optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants 44
MicroRNA from human peripheral blood leukocytes and cardiovascular diseases 43
Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity 43
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor 42
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients 42
?-Dystroglycan hypoglycosylation affects cell migration by influencing ?-dystroglycan membrane clustering and filopodia length: A musticale confocal microscopi analysis 42
A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics 42
Alpha-Dystroglycan is a potential target of matrix metalloproteinase MMP-2 41
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 41
The Multiple Affinities of alpha-Dystroglycan 41
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 39
Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain 39
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 38
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 38
Dystroglycan is associated to the disulfide isomerase ERp57 38
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? 38
Immunological dissection of the human dystroglycan complex 37
Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan 37
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 37
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan. 36
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 36
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 35
Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor 35
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 35
First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle 35
Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino. 34
±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging 34
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Idendification of the Main Cleavage Site 34
Mutagenesis of the ±- and ²- dystroglycan interface 34
A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. 33
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan 33
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex 33
Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders 33
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution 33
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 32
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 32
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex 31
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan. 31
Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives 31
Analysis at the molecular level of the interaction between alfa-dystroglycan and beta-dystroglycan 31
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. 31
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 31
The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation 30
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 30
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 30
Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope 30
FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies 29
Biochemical analysis of dystroglycan mutants involved in muscular dystrophies 29
Biochemical and cellular analysis of the dystroglycan alpha/beta interface 28
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection 28
Insertion of a myc-tag within ?-dystroglycan domains improves its biochemical and microscopic detection 28
The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture 28
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. 28
First genetic analysis of lattice corneal dystrophy type I in a family from Bulgaria 27
Identification of keratoepithelin in human skeletal muscle 27
Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newborns 26
Towards a reliable modeling approach for all dystroglycan domains 26
Alpha Dystroglycan monoclonal antibodies 25
MicroRNAs in human blood leukocytes and coronary angioplasy 24
Structural and functional aspects of dystroglycan: towards the elucidation of its pathophysiological role 23
Totale 5.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.834
article - articoli 9.701
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 126
Totale 25.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 6 6 4 2
2024/20251.706 1 6 115 48 393 217 16 117 51 66 390 286
2025/20263.017 114 232 283 375 374 125 318 116 805 106 113 56
2026/2027526 130 127 269 0 0 0 0 0 0 0 0 0
Totale 5.267